New Alzheimer's treatment has real promise and Medicare must grant access to it
Fox News
An experimental treatment gave Alzheimer's patients and their loved ones good news this week. Medicare must be part of the equation for patients as treatments become available.
Joe Grogan is a visiting senior fellow at the USC Schaeffer Center and served as director of the White House Domestic Policy Council under President Donald J. Trump. He consults with pharmaceutical companies including those working on Alzheimer’s treatments.
Around 6 million Americans have Alzheimer’s, and this number is expected to double over the coming decades. The disease devastates them and their loved ones’ lives. Several promising treatments target amyloid plaque in the brain, one of the early indicators of this devastating disease. Removing this plaque may transform the experience of people living with the early stage of the disease, as the promising new test results seem to confirm.
Dozens of House lawmakers rally around funding Afghan visa program as Trump vows major spending cuts
Reps. Jason Crow and Zach Nunn are leading 49 other House lawmakers in a letter urging Congress to preserve the Afghan Special Immigrant Visa program.